Annual ROA
-181.38%
+153.14%+45.78%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual return on assets is -181.38%, with the most recent change of +153.14% (+45.78%) on September 30, 2024.
- During the last 3 years, SONN annual ROA has fallen by -95.21% (-110.49%).
- SONN annual ROA is now -110.49% below its all-time high of -86.17%, reached on September 30, 2021.
Performance
SONN ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-150.14%
-8.01%-5.64%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly return on assets is -150.14%, with the most recent change of -8.01% (-5.64%) on September 30, 2024.
- Over the past year, SONN quarterly ROA has dropped by -8.01% (-5.64%).
- SONN quarterly ROA is now -2345.28% below its all-time high of -6.14%, reached on March 31, 2020.
Performance
SONN Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
SONN ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.8% | -5.6% |
| 3 y3 years | -110.5% | -5.6% |
| 5 y5 years | +98.5% | -5.6% |
SONN ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -110.5% | +45.8% | -19.0% | +47.2% |
| 5 y | 5-year | -110.5% | +98.5% | -2345.3% | +65.1% |
| alltime | all time | -110.5% | +98.5% | -2345.3% | +65.1% |
Sonnet BioTherapeutics Holdings ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -181.38%(-45.8%) | -150.14%(+5.6%) |
| Jun 2024 | - | -142.13%(+12.6%) |
| Mar 2024 | - | -126.19%(-31.8%) |
| Dec 2023 | - | -185.11%(-22.3%) |
| Sep 2023 | -334.52%(+96.0%) | -238.10%(-12.3%) |
| Jun 2023 | - | -271.47%(-4.6%) |
| Mar 2023 | - | -284.44%(+5.8%) |
| Dec 2022 | - | -268.86%(+41.3%) |
| Sep 2022 | -170.70% | -190.28%(+3.4%) |
| Jun 2022 | - | -184.02%(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -172.63%(-7.8%) |
| Dec 2021 | - | -187.27%(-17.8%) |
| Sep 2021 | -86.17%(-71.6%) | -227.86%(-47.0%) |
| Jun 2021 | - | -430.04%(+48.4%) |
| Mar 2021 | - | -289.83%(+23.6%) |
| Dec 2020 | - | -234.48%(+59.1%) |
| Sep 2020 | -303.53%(-97.5%) | -147.39%(+89.3%) |
| Jun 2020 | - | -77.85%(+1167.9%) |
| Mar 2020 | - | -6.14% |
| Sep 2019 | -12.24 K% | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual return on assets?
- What is the all time high annual ROA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual ROA year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly return on assets?
- What is the all time high quarterly ROA for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly ROA year-on-year change?
What is Sonnet BioTherapeutics Holdings annual return on assets?
The current annual ROA of SONN is -181.38%
What is the all time high annual ROA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual return on assets is -86.17%
What is Sonnet BioTherapeutics Holdings annual ROA year-on-year change?
Over the past year, SONN annual return on assets has changed by +153.14% (+45.78%)
What is Sonnet BioTherapeutics Holdings quarterly return on assets?
The current quarterly ROA of SONN is -150.14%
What is the all time high quarterly ROA for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly return on assets is -6.14%
What is Sonnet BioTherapeutics Holdings quarterly ROA year-on-year change?
Over the past year, SONN quarterly return on assets has changed by -8.01% (-5.64%)